Selective adjuvant radiation therapy for distant lymph node metastasis in patients with stage 4B epithelial ovarian cancer: a case series

Although the efficacy of surgery followed by taxane- and platinum-based systemic chemotherapy has been clearly demonstrated in the standard first-line treatment of epithelial ovarian cancer, the role of radiation therapy for distant lymph node metastasis in patients with epithelial ovarian cancer is...

Full description

Bibliographic Details
Main Authors: Eun Taeg Kim, Seung Yeon Oh, Sun Young Ma, Tae Hwa Lee, Won Gyu Kim
Format: Article
Language:English
Published: Kosin University College of Medicine 2023-12-01
Series:Kosin Medical Journal
Subjects:
Online Access:http://www.kosinmedj.org/upload/pdf/kmj-23-146.pdf
_version_ 1797372984272355328
author Eun Taeg Kim
Seung Yeon Oh
Sun Young Ma
Tae Hwa Lee
Won Gyu Kim
author_facet Eun Taeg Kim
Seung Yeon Oh
Sun Young Ma
Tae Hwa Lee
Won Gyu Kim
author_sort Eun Taeg Kim
collection DOAJ
description Although the efficacy of surgery followed by taxane- and platinum-based systemic chemotherapy has been clearly demonstrated in the standard first-line treatment of epithelial ovarian cancer, the role of radiation therapy for distant lymph node metastasis in patients with epithelial ovarian cancer is not well-established due to a lack of reported studies. We identified four patients who underwent selective adjuvant radiation therapy for neck and para-aortic lymph node lesions after primary debulking surgery between 2020 and 2022, followed by platinum-based chemotherapy for stage 4B high-grade serous ovarian cancer. Through a retrospective review of medical records, we analyzed patient clinicopathologic features, treatment course, and imaging findings. The median age was 49.25 years (range, 46–54 years). All patients had the International Federation of Gynecology and Obstetrics stage 4B disease. Following primary debulking surgery, all patients received weekly paclitaxel-carboplatin chemotherapy and maintenance treatment with poly(ADP-ribose) polymerase (PARP) inhibitors. All patients received selective adjuvant radiation therapy for neck and para-aortic lymph node metastasis before PARP inhibitor maintenance. The median follow-up time was 36.75 months (range, 19–45 months). All patients achieved a complete response. None of the patients experienced disease recurrence or died during the follow-up period. The management of distant lymph node metastasis in patients with epithelial ovarian cancer remains a matter of debate. Selective adjuvant radiation therapy in first-line treatment for ovarian cancer appears to be a feasible approach with maintenance therapy for stage 4B epithelial ovarian cancer.
first_indexed 2024-03-08T18:43:44Z
format Article
id doaj.art-27863a3df3d547158c85bcf9d58f4677
institution Directory Open Access Journal
issn 2005-9531
2586-7024
language English
last_indexed 2024-03-08T18:43:44Z
publishDate 2023-12-01
publisher Kosin University College of Medicine
record_format Article
series Kosin Medical Journal
spelling doaj.art-27863a3df3d547158c85bcf9d58f46772023-12-29T01:19:07ZengKosin University College of MedicineKosin Medical Journal2005-95312586-70242023-12-0138429329910.7180/kmj.23.1461264Selective adjuvant radiation therapy for distant lymph node metastasis in patients with stage 4B epithelial ovarian cancer: a case seriesEun Taeg Kim0Seung Yeon Oh1Sun Young Ma2Tae Hwa Lee3Won Gyu Kim4 Department of Obstetrics and Gynecology, Kosin University Gospel Hospital, Busan, Korea Department of Obstetrics and Gynecology, Kosin University Gospel Hospital, Busan, Korea Department of Radiology, Kosin University Gospel Hospital, Busan, Korea Department of Obstetrics and Gynecology, Kosin University Gospel Hospital, Busan, Korea Department of Obstetrics and Gynecology, Kosin University Gospel Hospital, Busan, KoreaAlthough the efficacy of surgery followed by taxane- and platinum-based systemic chemotherapy has been clearly demonstrated in the standard first-line treatment of epithelial ovarian cancer, the role of radiation therapy for distant lymph node metastasis in patients with epithelial ovarian cancer is not well-established due to a lack of reported studies. We identified four patients who underwent selective adjuvant radiation therapy for neck and para-aortic lymph node lesions after primary debulking surgery between 2020 and 2022, followed by platinum-based chemotherapy for stage 4B high-grade serous ovarian cancer. Through a retrospective review of medical records, we analyzed patient clinicopathologic features, treatment course, and imaging findings. The median age was 49.25 years (range, 46–54 years). All patients had the International Federation of Gynecology and Obstetrics stage 4B disease. Following primary debulking surgery, all patients received weekly paclitaxel-carboplatin chemotherapy and maintenance treatment with poly(ADP-ribose) polymerase (PARP) inhibitors. All patients received selective adjuvant radiation therapy for neck and para-aortic lymph node metastasis before PARP inhibitor maintenance. The median follow-up time was 36.75 months (range, 19–45 months). All patients achieved a complete response. None of the patients experienced disease recurrence or died during the follow-up period. The management of distant lymph node metastasis in patients with epithelial ovarian cancer remains a matter of debate. Selective adjuvant radiation therapy in first-line treatment for ovarian cancer appears to be a feasible approach with maintenance therapy for stage 4B epithelial ovarian cancer.http://www.kosinmedj.org/upload/pdf/kmj-23-146.pdfadjuvant radiotherapycase reportslymphatic metastasisovarian neoplasmspoly(adp-ribose) polymerase inhibitors
spellingShingle Eun Taeg Kim
Seung Yeon Oh
Sun Young Ma
Tae Hwa Lee
Won Gyu Kim
Selective adjuvant radiation therapy for distant lymph node metastasis in patients with stage 4B epithelial ovarian cancer: a case series
Kosin Medical Journal
adjuvant radiotherapy
case reports
lymphatic metastasis
ovarian neoplasms
poly(adp-ribose) polymerase inhibitors
title Selective adjuvant radiation therapy for distant lymph node metastasis in patients with stage 4B epithelial ovarian cancer: a case series
title_full Selective adjuvant radiation therapy for distant lymph node metastasis in patients with stage 4B epithelial ovarian cancer: a case series
title_fullStr Selective adjuvant radiation therapy for distant lymph node metastasis in patients with stage 4B epithelial ovarian cancer: a case series
title_full_unstemmed Selective adjuvant radiation therapy for distant lymph node metastasis in patients with stage 4B epithelial ovarian cancer: a case series
title_short Selective adjuvant radiation therapy for distant lymph node metastasis in patients with stage 4B epithelial ovarian cancer: a case series
title_sort selective adjuvant radiation therapy for distant lymph node metastasis in patients with stage 4b epithelial ovarian cancer a case series
topic adjuvant radiotherapy
case reports
lymphatic metastasis
ovarian neoplasms
poly(adp-ribose) polymerase inhibitors
url http://www.kosinmedj.org/upload/pdf/kmj-23-146.pdf
work_keys_str_mv AT euntaegkim selectiveadjuvantradiationtherapyfordistantlymphnodemetastasisinpatientswithstage4bepithelialovariancanceracaseseries
AT seungyeonoh selectiveadjuvantradiationtherapyfordistantlymphnodemetastasisinpatientswithstage4bepithelialovariancanceracaseseries
AT sunyoungma selectiveadjuvantradiationtherapyfordistantlymphnodemetastasisinpatientswithstage4bepithelialovariancanceracaseseries
AT taehwalee selectiveadjuvantradiationtherapyfordistantlymphnodemetastasisinpatientswithstage4bepithelialovariancanceracaseseries
AT wongyukim selectiveadjuvantradiationtherapyfordistantlymphnodemetastasisinpatientswithstage4bepithelialovariancanceracaseseries